Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Editorial Picks · page 4
- Prescribers & Clinics
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s CBPM prescribing record, raising further questions about assertions that ‘10 doctors prescribe half of the UK’s medical cannabis’.
- Cultivation
Cannabis Inherits Its Future: What the Eye Can’t See
‘Cannabis Inherits Its Future’ is a three-part feature covering the science, the bottlenecks and the path forward for cannabis breeding, written by Agential Cannabis.
- Industry Trends
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
In 2025, the UK imported more than 30,000 kilograms of cannabis-based medicinal products (CBPMs), more than doubling for the second consecutive year, new data from Prohibition Partners shows.
- International Regulation
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes.
- US & Canada
DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.
- Public Markets
Listed – Part II: The Three Amigos
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every large North American cannabis operator.
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
- Investment & Finance
Listed: Cannabis Finally Cracks America’s Major Exchanges
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.
- Patient Access
Ukraine Issues First Medical Cannabis Prescriptions, Two Years After Legalisation
First published on Cannabis Health On Thursday, 11 June, the first medical cannabis products were prescribed by neurologists at the Vinnytsia Regional Clinical Psychoneurological Hospital to Lyudmila Monastyrska, a patient with multiple sclerosis, and Yaroslav Yurchuk, a veteran who lost his leg a year ago while fighting in the Pokrovsk area.
- Medical Cannabis
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
The UK’s medical cannabis market has long been a locked box when it comes to reliable data.
- Interviews
From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light
Last year (fiscal year 2024/2025), Canada’s legal cannabis industry recorded revenues of CA$5.5bn, according to the latest figures from Statistics Canada.
- CBD Market
Latest French CBD Crackdown To Be Challenged In Court
French trade groups are seeking to overturn the ban on the sale of CBD food supplements in an attempted re-run of the successful 2022 removal of the ban on the sale of flowers.
